Nasdaq· Pharmaceutical Preparations· Inc. F4· CIK 0001809616

UPC

Universe Pharmaceuticals INC
$4.50 ▲ +4.41%
Prev close $4.31
Market cap$21.6M
Biotech & Drug Discovery
Snapshot
The big-picture read on UPC right now — valuation, ownership and activity at a glance.
Market Cap
$21.6M
Cap Size
Nano Cap
Social Sentiment
78° Bullish
SEC Reports
1
Price chart 30d +3.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 2, 2026 trading_halt
Halt Resumed: UPC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-02T13:34:02.000Z | Resumed 2026-09-02T13:39:02.000Z
Jul 3, 2026 SEC
Universe Pharmaceuticals (UPC) announced a share purchase agreement to acquire 100% of Best Praise International Limited
6-K — Impact 6/10
May 7, 2026 Insider
Lai Gang was granted 12,610 shares
Chief Executive Officer
May 7, 2026 Insider
Lai Gang was granted 71,890 shares
Chief Executive Officer
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
78°
Bullish
BearishNeutralBullish
5 mentions 5 bullish 0 bearish 0 neutral
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
1 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 0 neutral · avg impact 6.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 2, 2026
trading_halt
Halt Resumed: UPC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-02T13:34:02.000Z | Resumed 2026-09-02T13:39:02.000Z
Sep 2, 2026
trading_halt
Trading Halt: UPC — LUDP (Volatility Trading Pause)
Universe Pharma Ord A | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 2, 2026
short_volume
Short Volume: UPC — 55.4% short (0.3M / 0.6M)
Short: 309,034 | Exempt: 6,177 | TRF Vol: 557,938 | Short Ratio: 55.4% | Off-exchange volume (dark pool + OTC)
Aug 4, 2026
ftd
FTD: UPC — 174,246 shares ($1.1M) failed to deliver
Settlement: 20260804, Price: $6.48, FTD Value: $1,129,114.08, UNIVERSE PHARMACEUTICALS INC C
Jul 20, 2026
earnings_calendar
UPC Q2 2026 Earnings Scheduled — 2026-07-20
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.00$0.00–$0.00———$0.0B—
Next Q$0.00$0.00–$0.00———$0.0B—
Current FY$0.00$0.00–$0.00———$0.0B—
Next FY$0.00$0.00–$0.00———$0.0B—
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
1 insiders, 2 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
DateInsiderTitleTypeSharesPriceValue
May 7, 2026Lai GangChief Executive OfficerAWARD12,610——
May 7, 2026Lai GangChief Executive OfficerAWARD71,890——
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for UPC.
Shares short
75,844
Settlement Sep 15, 2026
Change vs prior
+154.8%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈1.5%
Estimate — not % of float
HaltedCodeReasonStatus
Sep 2, 2026LUDPVolatility PauseResumed
All UPC filing & press-release reports (1)